Friday, April 26, 2013

Docs call drugmakers 'profiteers' for costs of cancer meds - FiercePharma

via fiercepharma.com

The doctors called out as an example, Novartis' ($NVS) Gleevec, a treatment for chronic myeloid leukemia. They pointed out that it came on the market at a cost of $30,000 a year in 2001 and now runs three times that even though it now has competition.

Read more: Docs call drugmakers 'profiteers' for costs of cancer meds - FiercePharma http://www.fiercepharma.com/story/docs-call-drugmakers-profiteers-costs-cance...
Subscribe at FiercePharma

Posted via email from Jack's posterous

No comments: